Addressing antimicrobial resistance with the IDentif.AI platform: Rapidly optimizing clinically actionable combination therapy regimens against nontuberculous mycobacteria.
Theranostics
; 12(16): 6848-6864, 2022.
Article
in En
| MEDLINE
| ID: mdl-36276648
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mycobacterium abscessus
/
Nontuberculous Mycobacteria
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Theranostics
Year:
2022
Document type:
Article
Country of publication:
Australia